课题基金 / 基金详情

PIMAGEDINE IN PATIENTS WITH TYPE II DIABETES MELLITUS AND DIABETIC NEPHROPATHY

PIMAGEDINE IN PATIENTS WITH TYPE II DIABETES MELLITUS AND DIABETIC NEPHROPATHY
吡马地定治疗 II 型糖尿病和糖尿病肾病患者
批准号:
6114729
负责人:
William Irving Sivitz
金额:
$2.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

William Irving Sivitz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of the study is to evaluate the safety and efficacy of pimagedine, a nucleophilic hydrazine derivative, in preserving renal function in patients with type II diabetes mellitus and overt diabetic nephropathy. Parameters assessed include protein crosslinking, all-cause mortality, and cardiovascular mortality and morbidity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
  • 批准号:
    10263284
  • 项目类别:
  • 资助金额:
    $31.5万
  • 财政年份:
    2020
  • 负责人:
    William Irving Sivitz
  • 依托单位:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
  • 批准号:
    10428630
  • 项目类别:
  • 资助金额:
    $31.5万
  • 财政年份:
    2020
  • 负责人:
    William Irving Sivitz
  • 依托单位:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
  • 批准号:
    10119128
  • 项目类别:
  • 资助金额:
    $31.5万
  • 财政年份:
    2020
  • 负责人:
    William Irving Sivitz
  • 依托单位:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
  • 批准号:
    10643873
  • 项目类别:
  • 资助金额:
    $31.5万
  • 财政年份:
    2020
  • 负责人:
    William Irving Sivitz
  • 依托单位:
海外基金